Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-09-03 07:00 |
Valneva and Pfizer Report Further Positive Phase 2 Booster Results for Lyme Dis…
|
English | 208.5 KB | ||
| 2024-09-03 07:00 |
Valneva et Pfizer annoncent de nouvelles données positives de Phase 2 après une…
|
French | 238.1 KB | ||
| 2024-08-30 11:01 |
Franchissement de seuil
|
French | 210.9 KB | ||
| 2024-08-13 08:16 |
VALNEVA HALF-YEAR FINANCIAL REPORT
|
French | 1.6 MB | ||
| 2024-08-13 07:00 |
Valneva publie ses résultats financiers du premier semestre 2024 et fait un poi…
|
French | 321.9 KB | ||
| 2024-08-13 07:00 |
Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates
|
English | 303.4 KB | ||
| 2024-08-06 08:30 |
VALNEVA - Declaration of shares and voting rights: July 31, 2024
|
English | 14.8 KB | ||
| 2024-08-06 08:30 |
VALNEVA - Déclaration d’actions et de droits de vote : 31 juillet 2024
|
French | 14.4 KB | ||
| 2024-08-01 07:00 |
Valneva and LimmaTech Enter into a Strategic Partnership to Accelerate the Deve…
|
English | 218.2 KB | ||
| 2024-08-01 07:00 |
Valneva et LimmaTech signent un partenariat stratégique pour accélérer le dével…
|
French | 237.1 KB | ||
| 2024-07-24 09:08 |
Franchissements de seuils
|
French | 280.0 KB | ||
| 2024-07-22 07:00 |
CEPI renforce son partenariat avec Valneva en lui octroyant un nouveau financem…
|
French | 332.0 KB | ||
| 2024-07-22 07:00 |
CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Bro…
|
English | 349.9 KB | ||
| 2024-07-17 22:00 |
Essai de Phase 3 VALOR sur la maladie de Lyme : Valneva et Pfizer finalisent la…
|
French | 172.6 KB | ||
| 2024-07-17 22:00 |
Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccinati…
|
English | 202.5 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
